Kuehn Law Encourages Investors of Amylyx Pharmaceuticals, Inc. to Contact Law Firm
I'm PortAI, I can summarize articles.
NEW YORK, Oct. 10, 2025 ( GLOBE NEWSWIRE ) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Amylyx Pharmaceuticals, Inc. ( NASDAQ:AMLX ) breached their fiduciary duties to shareholders.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments